PL4396183T3 - Podstawione pochodne s-alaninianu - Google Patents

Podstawione pochodne s-alaninianu

Info

Publication number
PL4396183T3
PL4396183T3 PL22769666.3T PL22769666T PL4396183T3 PL 4396183 T3 PL4396183 T3 PL 4396183T3 PL 22769666 T PL22769666 T PL 22769666T PL 4396183 T3 PL4396183 T3 PL 4396183T3
Authority
PL
Poland
Prior art keywords
alaninate
derivatives
substituted
alaninate derivatives
Prior art date
Application number
PL22769666.3T
Other languages
English (en)
Inventor
Hartmut Beck
Stefanie MESCH
Alexandros Vakalopoulos
Nils PFAFF
Stefanie Zimmermann
Markus Follmann
Elisabeth KERSTEN
Guillaume Levilain
Katrin PARTIKEL
Andreas Peter BROEHL
Stefan Heitmeier
Julia DIETZE-TORRES
Lutz Lehmann
Kersten Matthias Gericke
Frank SÜSSMEIER
Lars BÄRFACKER
Alexander Hillisch
Adrian Tersteegen
Anja BUCHMÜLLER
Christoph Gerdes
Original Assignee
Bayer Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Aktiengesellschaft filed Critical Bayer Aktiengesellschaft
Publication of PL4396183T3 publication Critical patent/PL4396183T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41781,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL22769666.3T 2021-09-03 2022-08-29 Podstawione pochodne s-alaninianu PL4396183T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP21194781 2021-09-03
PCT/EP2022/073889 WO2023031083A1 (en) 2021-09-03 2022-08-29 Substituted s-alaninate derivatives

Publications (1)

Publication Number Publication Date
PL4396183T3 true PL4396183T3 (pl) 2026-02-09

Family

ID=77640441

Family Applications (1)

Application Number Title Priority Date Filing Date
PL22769666.3T PL4396183T3 (pl) 2021-09-03 2022-08-29 Podstawione pochodne s-alaninianu

Country Status (31)

Country Link
US (2) US20250002483A1 (pl)
EP (1) EP4396183B1 (pl)
JP (1) JP7546172B2 (pl)
KR (1) KR20240055043A (pl)
CN (1) CN117916236A (pl)
AR (1) AR126980A1 (pl)
AU (1) AU2022338082A1 (pl)
CA (1) CA3230721A1 (pl)
CL (1) CL2024000638A1 (pl)
CO (1) CO2024002668A2 (pl)
CR (1) CR20240114A (pl)
DK (1) DK4396183T3 (pl)
DO (1) DOP2024000024A (pl)
EC (1) ECSP24024658A (pl)
ES (1) ES3055022T3 (pl)
FI (1) FI4396183T3 (pl)
GE (2) GEAP202416491A (pl)
HR (1) HRP20251414T1 (pl)
IL (1) IL310777A (pl)
JO (1) JOP20240043A1 (pl)
LT (1) LT4396183T (pl)
MA (1) MA66371B1 (pl)
MX (1) MX2024002750A (pl)
PE (1) PE20240798A1 (pl)
PL (1) PL4396183T3 (pl)
PT (1) PT4396183T (pl)
RS (1) RS67431B1 (pl)
SI (1) SI4396183T1 (pl)
TW (1) TW202320754A (pl)
WO (1) WO2023031083A1 (pl)
ZA (1) ZA202402553B (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4669644A1 (en) * 2023-02-21 2025-12-31 Bayer Aktiengesellschaft SUBSTITUTED S-ALANINATE DERIVATIVES
WO2025237307A1 (zh) * 2024-05-14 2025-11-20 苏州康宁杰瑞生物科技有限公司 凝血因子FXI/FXIa抑制剂用于治疗肺动脉高压和/或高血压
CN119366487A (zh) * 2024-10-30 2025-01-28 健帆生物科技集团股份有限公司 一种用于血液灌流器对内毒素吸附性能的评价方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0042675A1 (en) 1980-06-20 1981-12-30 Norton Company Method of mounting a grinding wheel on a spindle
ES2394550T3 (es) 2008-02-21 2013-02-01 Sanofi Clorotiofen-amidas como inhibidores de los factores Xa de coagulación y trombina
WO2014174102A1 (en) 2013-04-26 2014-10-30 Sanofi Tartrate salt of 5-chloro-thiophene-2-carboxylic acid [(s)-2-[methyl-3-(2-oxo-pyrrolidin-1-yl)-benzenesulfonylamino]-3-(4-methyl piperazin-1 -yl)-3-oxo-propryl]amide

Also Published As

Publication number Publication date
DOP2024000024A (es) 2024-03-28
ECSP24024658A (es) 2024-04-30
AR126980A1 (es) 2023-12-06
TW202320754A (zh) 2023-06-01
KR20240055043A (ko) 2024-04-26
MX2024002750A (es) 2024-03-27
GEAP202416491A (en) 2024-05-10
CO2024002668A2 (es) 2024-03-07
HRP20251414T1 (hr) 2026-01-02
GEP20257776B (en) 2025-06-25
CA3230721A1 (en) 2023-03-09
IL310777A (en) 2024-04-01
EP4396183A1 (en) 2024-07-10
CR20240114A (es) 2024-05-22
MA66371B1 (fr) 2025-12-31
AU2022338082A1 (en) 2024-02-15
SI4396183T1 (sl) 2026-01-30
ES3055022T3 (en) 2026-02-09
RS67431B1 (sr) 2025-12-31
LT4396183T (lt) 2025-11-25
ZA202402553B (en) 2025-09-25
CL2024000638A1 (es) 2024-07-05
PE20240798A1 (es) 2024-04-18
DK4396183T3 (da) 2025-11-17
PT4396183T (pt) 2025-11-25
EP4396183B1 (en) 2025-09-03
CN117916236A (zh) 2024-04-19
WO2023031083A1 (en) 2023-03-09
FI4396183T3 (fi) 2025-12-04
US20230391761A1 (en) 2023-12-07
US11912692B2 (en) 2024-02-27
JP2024509511A (ja) 2024-03-04
JP7546172B2 (ja) 2024-09-05
US20250002483A1 (en) 2025-01-02
JOP20240043A1 (ar) 2024-02-29

Similar Documents

Publication Publication Date Title
ZA202204675B (en) New methylquinazolinone derivatives
SI3958977T1 (sl) Derivati kamptotecina
HUE070924T2 (hu) 2-Hidroxicikloalkán-1-karbamoil-származékok
IL290815A (en) History of alpha-d-galactopyranoside
PL4077334T3 (pl) Pochodne furoindazolu
IL283990A (en) Modified oxopyridine derivatives
ZA202106024B (en) Heterocyclic derivatives
GB202018994D0 (en) Herbicidal derivatives
PT4396183T (pt) Derivados substituídos de s-alaninato
IL290964A (en) A 2-aminoquinazolinone derivative
GB202018996D0 (en) Herbicidal derivatives
HUE070859T2 (hu) Rapamicin-származékok
SG11202012594RA (en) Spirochromane derivatives
PL3796975T3 (pl) Pochodne sulfonyloaminobenzamidu
GB202007419D0 (en) Herbicidal derivatives
IL288950A (en) History of pyridine-3-yl
HUE062256T2 (hu) Dihidrokromén-származékok
ES3063388T3 (en) Dihydrocyclopenta-isoquinoline-sulfonamide derivatives compounds
IL304189A (en) Pyrazolamide derivatives
GB201919210D0 (en) Dihydro-cyclopenta-isoquinoline derivatives
IL319945A (en) New Modified Pyrazine-Carboxamide History
ZA202200181B (en) 2-hydroxycycloalkane-1-carbamoyl derivatives
GB201906269D0 (en) Microbiocidal derivatives
GB201906272D0 (en) Microbiocidal derivatives
GB201906274D0 (en) Microbiocidal derivatives